系统性红斑狼疮中的细胞因子
Cytokines in systemic lupus erythematosus.
作者信息
Lourenço Elaine V, La Cava Antonio
机构信息
Division of Rheumatology, Department of Medicine, University of California Los Angeles, Los Angeles, CA 90095-1670, USA.
出版信息
Curr Mol Med. 2009 Apr;9(3):242-54. doi: 10.2174/156652409787847263.
Abstract
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the production of autoantibodies that can form immune complexes and deposit in tissues, causing inflammation and organ damage. There is evidence that interferons and some interleukins can have an active role in the pathogenesis of SLE and can contribute significantly to the immune imbalance in the disease, whereas the role of some cytokines (such as TNF) is still debated. This review discusses the activity of several cytokines in SLE, their effects on the immune cells in relation to the disease pathogenesis, and the promise and limitations of cytokine-based therapies in clinical trials for lupus patients.
摘要
系统性红斑狼疮（SLE）是一种慢性自身免疫性疾病，其特征是产生自身抗体，这些自身抗体可形成免疫复合物并沉积在组织中，导致炎症和器官损伤。有证据表明，干扰素和一些白细胞介素在SLE的发病机制中可发挥积极作用，并可显著导致该疾病的免疫失衡，而一些细胞因子（如肿瘤坏死因子）的作用仍存在争议。本综述讨论了几种细胞因子在SLE中的活性、它们在疾病发病机制方面对免疫细胞的影响，以及基于细胞因子的疗法在狼疮患者临床试验中的前景和局限性。
相似文献
1
Cytokines in systemic lupus erythematosus.
Curr Mol Med. 2009 Apr;9(3):242-54. doi: 10.2174/156652409787847263.
2
BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Cytokine. 2019 Feb;114:115-127. doi: 10.1016/j.cyto.2018.11.008. Epub 2018 Nov 19.
3
T helper cell subsets in the pathogenesis of systemic lupus erythematosus.
Ann Med Interne (Paris). 1996;147(7):467-71.
4
T follicular helper cells, interleukin-21 and systemic lupus erythematosus.
Rheumatology (Oxford). 2017 Apr 1;56(4):516-523. doi: 10.1093/rheumatology/kew297.
5
A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren's syndrome and systemic lupus erythematosus.
Clin Exp Immunol. 2016 Jan;183(1):76-89. doi: 10.1111/cei.12703. Epub 2015 Oct 21.
6
Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus.
Clin Exp Immunol. 2010 Jan;159(1):11-22. doi: 10.1111/j.1365-2249.2009.04036.x. Epub 2009 Oct 16.
7
T follicular helper (Tfh) cells in lupus: Activation and involvement in SLE pathogenesis.
Eur J Immunol. 2016 Feb;46(2):281-90. doi: 10.1002/eji.201545760.
8
Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production.
Lupus. 2015 Aug;24(9):909-17. doi: 10.1177/0961203314567750. Epub 2015 Feb 5.
9
NF-κB and systemic lupus erythematosus: examining the link.
J Nephrol. 2013 Nov-Dec;26(6):953-9. doi: 10.5301/jn.5000272. Epub 2013 Jun 14.
10
New insights into the immunopathogenesis of systemic lupus erythematosus: the role of T follicular helper cells.
Chin Med J (Engl). 2014;127(19):3496-502.
引用本文的文献
1
Cytotoxic Molecules as Potential Biomarkers for Active and Inactive Systemic Lupus Erythematosus.
Biomedicines. 2025 Jun 25;13(7):1559. doi: 10.3390/biomedicines13071559.
2
C1q Binds to CD4+ T Cells and Inhibits the Release of Pro-Inflammatory Cytokines: Role in the Pathogenesis of Systemic Lupus Erythematosus.
Int J Mol Sci. 2025 May 8;26(10):4468. doi: 10.3390/ijms26104468.
3
Kynurenines as a Novel Target for the Treatment of Inflammatory Disorders.
Cells. 2024 Jul 26;13(15):1259. doi: 10.3390/cells13151259.
4
DNA corona on nanoparticles leads to an enhanced immunostimulatory effect with implications for autoimmune diseases.
Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2319634121. doi: 10.1073/pnas.2319634121. Epub 2024 Mar 5.
5
Leveraging Lymphatic System Targeting in Systemic Lupus Erythematosus for Improved Clinical Outcomes.
Pharmacol Rev. 2024 Feb 13;76(2):228-250. doi: 10.1124/pharmrev.123.000938.
6
Imbalance of helper T cell type 1, helper T cell type 2 and associated cytokines in patients with systemic lupus erythematosus: A meta-analysis.
Front Pharmacol. 2022 Sep 29;13:988512. doi: 10.3389/fphar.2022.988512. eCollection 2022.
7
CD4+ Cytotoxic T Cells Involved in the Development of EBV-Associated Diseases.
Pathogens. 2022 Jul 25;11(8):831. doi: 10.3390/pathogens11080831.
8
Lack of Association between Serum Interleukin-23 and Interleukin-27 Levels and Disease Activity in Patients with Active Systemic Lupus Erythematosus.
J Clin Med. 2021 Oct 19;10(20):4788. doi: 10.3390/jcm10204788.
9
Bone Marrow Multipotent Mesenchymal Stromal Cells as Autologous Therapy for Osteonecrosis: Effects of Age and Underlying Causes.
Bioengineering (Basel). 2021 May 17;8(5):69. doi: 10.3390/bioengineering8050069.
10
Salivary Cytokines as Potential Diagnostic Biomarkers for Systemic Lupus Erythematosus Disease.
Mediators Inflamm. 2021 Mar 11;2021:8847557. doi: 10.1155/2021/8847557. eCollection 2021.
本文引用的文献
1
Pillars Article: An Essential Role for Scurfin in CD4+CD25+ T Regulatory Cells. Nat. Immunol. 2003. 4: 337-342.
J Immunol. 2017 Feb 1;198(3):993-998.
2
Pillars Article: Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells. Nat. Immunol. 2003. 4: 330-336.
J Immunol. 2017 Feb 1;198(3):986-992.
3
Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomerulonephritis.
Nephrol Dial Transplant. 2008 Nov;23(11):3418-26. doi: 10.1093/ndt/gfn314. Epub 2008 Jun 13.
4
Role of Toll like receptor-activated dendritic cells in the development of autoimmunity.
Front Biosci. 2008 May 1;13:4817-26. doi: 10.2741/3041.
5
T-regulatory cells in systemic lupus erythematosus.
Lupus. 2008 May;17(5):421-5. doi: 10.1177/0961203308090028.
6
A peptide that ameliorates lupus up-regulates the diminished expression of early growth response factors 2 and 3.
J Immunol. 2008 Feb 1;180(3):1584-91. doi: 10.4049/jimmunol.180.3.1584.
7
The genetics and biology of Irf5-mediated signaling in lupus.
Autoimmunity. 2007 Dec;40(8):591-601. doi: 10.1080/08916930701510905.
8
STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus.
N Engl J Med. 2007 Sep 6;357(10):977-86. doi: 10.1056/NEJMoa073003.
9
Ifi202, an IFN-inducible candidate gene for lupus susceptibility in NZB/W F1 mice, is a positive regulator for NF-kappaB activation in dendritic cells.
Int Immunol. 2007 Aug;19(8):935-42. doi: 10.1093/intimm/dxm054. Epub 2007 Aug 16.
10
Activation of the signal transducer and activator of transcription-1 in diffuse proliferative lupus nephritis.
Lupus. 2007;16(7):483-8. doi: 10.1177/0961203307079618.
Zotero 插件